Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development
NCT02812446 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88
Last updated 2016-06-24
Summary
The purpose of this study is to identify bacterial and/or clinical features involved in the pathogenesis of Staphylococcus aureus implant-associated infections (IAI). Materials \& methods: In total, 57 IAI S. aureus and 31 nasal carriage (NC) S. aureus isolates were studied. Staphylococcus aureus genetic background was obtained by microarray analysis. Multilocus sequence typing was performed to determine clonal complexes (CC). Biofilm production was investigated by resazurin and crystal violet methods
Conditions
- Staphylococcal Infection
Interventions
- OTHER
-
IAI infection
- OTHER
-
Staphylococcus aureus nasal carriage infection
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2012-09-30
- Completion
- 2013-12-31
More Related Trials
-
Rifampin-combined Antibiotic Therapy for Staphylococcal PJI
NCT07313215 ·Status: RECRUITING ·Phase: NA
-
Virulence of Staphylococcus Lugdunensis in Severe Infections
NCT02026895 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections
NCT02378493 ·Status: COMPLETED ·Phase: NA
-
Assessing Parenteral Antibiotics Versus Single-time Intra-operative Intra-dermal Antibiotic Administration for Prevention of SSI
NCT04975945 ·Status: WITHDRAWN ·Phase: PHASE4
-
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
NCT00519025 ·Status: COMPLETED
-
Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections
NCT02640937 ·Status: COMPLETED
-
Postoperative Antibiotics Following Primary and Secondary Breast Augmentation
NCT04834310 ·Status: WITHDRAWN ·Phase: PHASE4
-
Biofilm Formation and Antibiotic Sensitivity Patterns
NCT05181163 ·Status: UNKNOWN
-
Linezolid-resistant Staphylococcus Epidermidis in ICU and Risk Factors Analysis
NCT03140410 ·Status: UNKNOWN
-
Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.
NCT05369104 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia
NCT03163446 ·Status: COMPLETED ·Phase: PHASE2
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
NCT05655091 ·Status: RECRUITING ·Phase: PHASE2
-
Local Antibiotics for Breast Implants
NCT04731025 ·Status: RECRUITING ·Phase: PHASE3
-
Short Against Long Antibiotic Therapy for Infected Orthopedic Sites
NCT05499481 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia
NCT01911624 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.
NCT01875263 ·Status: TERMINATED ·Phase: PHASE3
-
Microbiome and Association With Implant Infections
NCT05020574 ·Status: RECRUITING ·Phase: PHASE2
-
Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia
NCT06726395 ·Status: RECRUITING ·Phase: PHASE4
-
Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia
NCT00505258 ·Status: WITHDRAWN ·Phase: PHASE2
-
Plasma Pharmacological Monitoring of M Penicillins in Methicillin-sensitive Staphylococcus Aureus Bacteremia
NCT06495697 ·Status: RECRUITING
-
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
NCT01792804 ·Status: COMPLETED ·Phase: PHASE3
-
Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia
NCT03514446 ·Status: UNKNOWN ·Phase: PHASE4
-
Pathogenicity Factors of Staphylococcus Pettenkoferi in Foot Wounds and Osteitis in Diabetic Patients
NCT06688084 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Evaluation of Daptomycin Bone Penetration
NCT01306825 ·Status: UNKNOWN